DGAP-News
AMP German Cannabis Group Hires Experienced Sales Director from Canopy Growth - Seite 2
Mr. Marc Wälken, Sales Director of AMP, commented: "I believe that AMP's strategy of focusing on supplying mid-sized pharmaceutical distributors and big pharmacies will be successful, especially as AMP will invest in information events for pharmacists and doctors, thus enlarging their knowledge about the medical use of its medical cannabis products."
About AMP German Cannabis Group
AMP German Cannabis Group is licensed to import European Union - Good Manufacturing Practice (EU-GMP) medical cannabis and sell to pharmaceutical distributors or pharmacists directly, the only point-of-sale for medical cannabis to German patients.
AMP has entered into a non-exclusive distribution agreement for medical cannabis with a leading distributor of pharmaceuticals products to more than 13,000 pharmacies throughout Germany. AMP imports medical cannabis from the Netherlands and beginning in the second half of 2020 also from Canada.
For more information, please visit: www.amp-eu.com
Contact:
Mr. Alex Blodgett, CEO and Director
Lesen Sie auch
Telephone: +1 236-833-1602
Email: investor@amp-eu.com
AMP social media links:
- Twitter: https://twitter.com/AMP_Cannabis
- LinkedIn: www.linkedin.com/company/ampgermancannabisgroup
- Facebook: www.facebook.com/AMPGCG/
- Instagram: www.instagram.com/ampgcg/
Media Kit: www.amp-eu.com/media-kit
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking statements that are based on the Company's expectations, estimates and projections regarding its business and the economic environment in which it
operates, including with respect to its business plans and milestones and the timing thereof. Although the Company believes the expectations expressed in such forward-looking statements are based
on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and
results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as
of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise
required to do so by law.
SOURCE AMP German Cannabis Group Inc.
15.09.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
1131683 15.09.2020